| http://www.w3.org/ns/prov#value | - VIVALIS offers research and commercial licenses for its EB66?? cell line, derived from duck stem cells, to pharmaceutical and biotechnology companies for the production of therapeutic and prophylactic viral vaccines, virosomes, VLPs and recombinant proteins, especially monoclonal antibodies with enhanced cytotoxic activity.
|
